These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
580 related items for PubMed ID: 8276356
1. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Um SH, Nishida O, Tokubayashi M, Kimura F, Takimoto Y, Yoshioka H, Inque R, Kita T. Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356 [Abstract] [Full Text] [Related]
2. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model]. Wang CT, Kuang YL, Chen ZP. Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436 [Abstract] [Full Text] [Related]
3. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841 [Abstract] [Full Text] [Related]
4. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension. Resch M, Wiest R, Moleda L, Fredersdorf S, Stoelcker B, Schroeder JA, Schölmerich J, Endemann DH. Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142 [Abstract] [Full Text] [Related]
5. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models]. Zhou YB, Leng X, Qi G. Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550 [Abstract] [Full Text] [Related]
6. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats. Zhang B, Zhang CG, Zhou QB, Chen W, Wu ZY. World J Gastroenterol; 2013 Oct 28; 19(40):6863-8. PubMed ID: 24187462 [Abstract] [Full Text] [Related]
7. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats. Blanchart A, Garrido MC, Fernández-Muñoz D, Nuño J, Hernando L, López-Novoa JM. Rev Esp Fisiol; 1984 Dec 28; 40(4):493-9. PubMed ID: 6397796 [Abstract] [Full Text] [Related]
8. Effects of long-term administration of octreotide in portal vein-stenosed rats. Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, Tsai YT, Lee SD. Hepatology; 1996 Mar 28; 23(3):537-43. PubMed ID: 8617434 [Abstract] [Full Text] [Related]
9. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats. Heinemann A, Schuligoi R, Lippe IT, Stauber RE. Pharmacology; 2009 Mar 28; 83(1):26-32. PubMed ID: 18987488 [Abstract] [Full Text] [Related]
10. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Vorobioff J, Bredfeldt JE, Groszmann RJ. Am J Physiol; 1983 Jan 28; 244(1):G52-7. PubMed ID: 6849394 [Abstract] [Full Text] [Related]
11. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY. Hepatobiliary Pancreat Dis Int; 2006 Nov 28; 5(4):564-9. PubMed ID: 17085343 [Abstract] [Full Text] [Related]
12. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation. Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J. Hepatology; 1993 Aug 28; 18(2):389-93. PubMed ID: 8340068 [Abstract] [Full Text] [Related]
13. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique]. Pérez-Páramo M, Muñoz J, Albillos A, Rossi I, Alvarez-Mon M, Ortiz Berrocal J. Rev Esp Med Nucl; 1998 Aug 28; 17(4):294-301. PubMed ID: 9721346 [Abstract] [Full Text] [Related]
14. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats. Lin HC, Soubrane O, Lebrec D. Hepatology; 1991 Aug 28; 14(2):325-30. PubMed ID: 1860689 [Abstract] [Full Text] [Related]
15. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. Hou MC, Cahill PA, Zhang S, Wang YN, Hendrickson RJ, Redmond EM, Sitzmann JV. Hepatology; 1998 Jan 28; 27(1):20-7. PubMed ID: 9425912 [Abstract] [Full Text] [Related]
16. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension]. Albornoz L, Bandi JC, Sánchez S, Spinedi E, Canteros G, De Paula JA, Galdame O, Mastai R. Medicina (B Aires); 1994 Jan 28; 54(1):17-24. PubMed ID: 7990681 [Abstract] [Full Text] [Related]
18. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Fernandez M, Mejias M, Garcia-Pras E, Mendez R, Garcia-Pagan JC, Bosch J. Hepatology; 2007 Oct 28; 46(4):1208-17. PubMed ID: 17654489 [Abstract] [Full Text] [Related]
19. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats]. Wu Z, Zhou J, Chen Z, Zhou H, Jiao Z, Kuang Y, Yuan J, Wang Q, Zeng M. Zhonghua Wai Ke Za Zhi; 1998 Mar 28; 36(3):182-6. PubMed ID: 11825365 [Abstract] [Full Text] [Related]
20. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Sikuler E, Kravetz D, Groszmann RJ. Am J Physiol; 1985 Jun 28; 248(6 Pt 1):G618-25. PubMed ID: 4003545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]